JIANGXI SANXIN MEDTEC CO.,LTD. Jiangxi Sanxin Medtec Co.,Ltd. Share Price
Equities
300453
CNE100001ZJ1
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.83 CNY | +3.16% |
|
+8.90% | +2.62% |
| Sales 2022 | 1.34B 185M 14.76B | Sales 2023 | 1.3B 180M 14.36B | Capitalization | 3.96B 548M 43.79B |
|---|---|---|---|---|---|
| Net income 2022 | 185M 25.55M 2.04B | Net income 2023 | 207M 28.59M 2.29B | EV / Sales 2022 | 2.39 x |
| Net cash position 2022 | 232M 32.04M 2.56B | Net cash position 2023 | 160M 22.05M 1.76B | EV / Sales 2023 | 2.93 x |
| P/E ratio 2022 |
18.5
x | P/E ratio 2023 |
19.2
x | Employees | 1,927 |
| Yield 2022 |
1.74% | Yield 2023 |
1.51% | Free-Float | 53.87% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.16% | ||
| 1 week | +8.90% | ||
| Current month | +7.41% | ||
| 1 month | +7.41% | ||
| 3 months | +16.87% | ||
| 6 months | +2.35% | ||
| Current year | +2.62% |
1 week
7.22
7.89
1 month
7.097.98
Current year
4.887.98
1 year
4.888.18
3 years
4.8813.52
5 years
3.2813.95
10 years
2.5016.38
| Managers | Title | Age | Since |
|---|---|---|---|
Bei Ting Zou
DFI | Director of Finance/CFO | 38 | 31/08/19 |
Zhi Ping Mao
PSD | President | 50 | 30/11/03 |
Yi Xing Peng
CHM | Chairman | 66 | 06/03/97 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lin Zhang
BRD | Director/Board Member | 41 | 31/12/01 |
Yi Xing Peng
CHM | Chairman | 66 | 06/03/97 |
Feng Lian Lei
BRD | Director/Board Member | 63 | 06/03/97 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.08% | 12 M€ | -16.71% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 7.83 | +3.16% | 7 395 367 |
| 29/04/24 | 7.59 | +2.02% | 5,398,754 |
| 26/04/24 | 7.44 | +1.50% | 4,753,446 |
| 25/04/24 | 7.33 | -0.81% | 4,129,885 |
| 24/04/24 | 7.39 | +0.96% | 3,613,546 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes
Jiang Xi Sanxin Medtec Co., Ltd. is a China-based company principally engaged in research, development, manufacture and sales of disposable sterile injection medical devices. The Company's products include five series: syringe series, infusion & transfusion series, catheter tubing series, blood purification series and other series. The Company distributes its products within the domestic markets and to overseas markets.
Calendar
29/08/2024
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +2.62% | 536M | |
| -3.72% | 186B | |
| -2.60% | 107B | |
| -3.79% | 67.44B | |
| +2.66% | 50.03B | |
| +16.39% | 47.81B | |
| +4.79% | 41.03B | |
| +1.38% | 26.85B | |
| +1.52% | 25.82B | |
| -1.17% | 25.01B |
- Stock Market
- Equities
- 300453 Stock
